Arenaviridae

Arenaviridae
Sarah Katharina Fehling, Frank Lennartz, and Thomas Strecker · CC BY 4.0 · source
Name	Arenaviridae
Taxon	Arenaviridae
Subdivision ranks	Genera

Arenaviridae Arenaviridae is a family of enveloped, negative-sense RNA viruses first recognized in the mid-20th century during outbreaks in South America and West Africa. Members of this family include medically important agents associated with hemorrhagic fevers and neurologic disease; study and response efforts have involved organizations such as the World Health Organization, Centers for Disease Control and Prevention, Pan American Health Organization, and national public health institutes. Research on arenaviruses has engaged virologists, epidemiologists, and vaccine developers at institutions like the National Institutes of Health, Rockefeller University, Institut Pasteur, and Walter Reed Army Institute of Research.

Taxonomy and classification

Arenaviridae is classified within the order Bunyavirales (note: historical sources placed arenaviruses elsewhere) and is divided into several genera recognized by the International Committee on Taxonomy of Viruses; major genera include Old World and New World lineages that correspond to geographic associations tied to regions such as West Africa, Southern Europe, South America, and Central America. Notable species within the family include well-known agents like Lassa virus (linked to Nigeria and Sierra Leone outbreaks), Junín virus (linked to Argentine hemorrhagic fever and studies at Instituto Nacional de Enfermedades Infecciosas), Machupo virus (Bolivia), Guanarito virus (Venezuela), and Sabia virus (Brazil), as well as rodent-associated species described in ecological surveys by groups at Smithsonian Institution and regional universities. Taxonomic revisions have been influenced by phylogenetic analyses using sequence data deposited in databases such as GenBank and by comparative studies published in journals like Journal of Virology and Nature Microbiology.

Structure and genome

Arenaviridae virions are pleomorphic, enveloped particles approximately 40–200 nm in diameter, often containing characteristic ribosome-like granules first noted by researchers at Rockefeller University; electron microscopy work at institutions such as Cold Spring Harbor Laboratory helped define morphology. The genome is bi-segmented, single-stranded, ambisense RNA with large (L) and small (S) segments encoding proteins including the RNA-dependent RNA polymerase (L protein), the glycoprotein precursor (GPC), the nucleoprotein (NP), and the zinc-binding matrix protein (Z). Comparative genomic studies using sequence data from EMBL-EBI, DNA Data Bank of Japan, and GenBank show conserved promoter structures and gene order across Old World and New World arenaviruses, while glycoprotein cleavage sites and receptor-binding domains vary, informing structural biology investigations at facilities like European Molecular Biology Laboratory and Rutherford Appleton Laboratory.

Replication and lifecycle

Arenaviridae replication begins with attachment of viral glycoproteins to host receptors; Old World viruses such as Lassa virus use receptors including alpha-dystroglycan (studied by teams at University of California, San Diego), while several New World viruses engage human transferrin receptor 1 as demonstrated by structural virology groups at Scripps Research Institute and University of Oxford. After receptor-mediated endocytosis and membrane fusion in endosomes, the viral ribonucleoprotein complexes are released and transcription of ambisense segments occurs in the cytoplasm, relying on the L polymerase and NP cofactor—mechanisms elucidated in biochemical studies at Max Planck Institute and University of Tokyo. Viral assembly at cellular membranes involves the Z protein budding process, a target of antiviral research by groups at Harvard Medical School and University of Pennsylvania, and progeny virions are released to infect new cells, a cycle documented in cell-culture experiments using lines from American Type Culture Collection.

Hosts and transmission

Rodents are the primary reservoirs for most arenaviruses, with host associations identified in field studies by teams from Smithsonian Institution, London School of Hygiene and Tropical Medicine, and regional universities in South America and Africa; species such as Mastomys natalensis (associated with Lassa virus) and Calomys musculinus (associated with Junín virus) are central to zoonotic transmission ecology. Human infection typically results from aerosolized excreta, direct contact with contaminated materials, or rodent bites; nosocomial transmission has been documented in hospital outbreaks investigated by Médecins Sans Frontières and national health ministries. Secondary transmission routes, including person-to-person spread during outbreaks in settings evaluated by World Health Organization response teams, have shaped public health interventions in countries like Nigeria, Argentina, Bolivia, and Venezuela.

Diseases and clinical manifestations

Clinical presentations range from mild febrile illness to severe hemorrhagic fever with multisystem involvement; Lassa fever is characterized by fever, sore throat, myalgia, and in severe cases hemorrhage, shock, and auditory damage, with sequelae documented in longitudinal studies at University of Lagos and Kenema Government Hospital. New World hemorrhagic fevers—such as Argentine hemorrhagic fever caused by Junín virus—can present with thrombocytopenia, neurologic signs, and high case fatality without treatment, as described in outbreak reports by Instituto Nacional de Enfermedades Infecciosas and historical summaries in The Lancet. Risk groups identified in occupational and epidemiologic studies include healthcare workers, agricultural laborers, and inhabitants of rodent-infested environments in regions covered by organizations like Pan American Health Organization.

Diagnosis, treatment, and prevention

Diagnosis relies on molecular assays (RT-PCR) developed in laboratories at Centers for Disease Control and Prevention, serology (ELISA) validated by research centers at Institut Pasteur, and antigen detection methods used in field settings supported by World Health Organization field teams. Treatment options are limited; ribavirin has shown efficacy in early Lassa fever clinical use documented in collaborative trials involving Walter Reed Army Institute of Research and regional hospitals, while supportive care and strict infection-control measures are cornerstones of management as applied by Médecins Sans Frontières. Preventive strategies encompass rodent control programs coordinated by national ministries of health, laboratory biosafety protocols enforced by agencies such as Occupational Safety and Health Administration in applicable jurisdictions, and vaccine development efforts led by consortia including National Institutes of Health, academic vaccinology groups at University of Oxford and biotech firms engaged in clinical trials. Surveillance networks coordinated by World Health Organization and regional public health bodies remain critical for early detection and outbreak response.

Category:Virus families